Skip to main content
VCbacked
Log inGet Started

TippingPoint Biosciences

San Francisco, United States

TippingPoint Biosciences is developing therapeutics that target genome packaging states in diseases like cancer.

$4.5M raised
Mar 2026
Seed
Biotechnology

Top Investors

Sazze PartnersMission BioCapitalSOSVSOSV SF & NY (Fka IndieBio)Freeflow Ventures

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about TippingPoint Biosciences

How much funding has TippingPoint Biosciences raised?
TippingPoint Biosciences has raised $4.5M in total funding. The most recent round was Seed. The last funding was announced in March 2026.
Who are TippingPoint Biosciences's investors?
TippingPoint Biosciences's investors include Sazze Partners, Mission BioCapital, SOSV, SOSV SF & NY (Fka IndieBio), Freeflow Ventures.
Where is TippingPoint Biosciences headquartered?
TippingPoint Biosciences is headquartered in San Francisco, United States.
What does TippingPoint Biosciences do?
TippingPoint Biosciences is developing therapeutics that target genome packaging states in diseases like cancer.
What stage is TippingPoint Biosciences at?
TippingPoint Biosciences is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"TippingPoint Biosciences — Funding & Investors." VCBacked, March 31, 2026, https://www.vcbacked.co/company/tippingpoint-biosciences. Accessed July 7, 2026.
APA
VCBacked. (2026). TippingPoint Biosciences — Funding & Investors. Retrieved July 7, 2026, from https://www.vcbacked.co/company/tippingpoint-biosciences
Wikipedia (cite web)
{{cite web |title=TippingPoint Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/tippingpoint-biosciences |website=VCBacked |access-date=July 7, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Allterum Therapeutics
Houston$1.0M
Renaissance BioScience
Vancouver$599K
AlpalifeBio
Woburn$9.8M
Rapport Therapeutics
Boston$250.0M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K